1,210
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

The Prevalence and Symptom Profile of Asthma–COPD Overlap: The HUNT Study

, , , &
Pages 27-35 | Received 16 Aug 2017, Accepted 17 Nov 2017, Published online: 19 Dec 2017

References

  • Abramson MJ, Perret JL, Dharmage SC, McDonald VM, McDonald CF. Distinguishing adult-onset asthma from COPD: a review and a new approach. Int J Chronic Obstruct Pulm Dis. 2014;9:945–962. doi:10.2147/COPD.S46761.
  • Global initiative for Chronic Obstructive Lung Disease. Asthma, COPD and Asthma-COPD Overlap Syndrome. GOLD [Internet]. 2015. Available from: http://goldcopd.org/asthma-copd-asthma-copd-overlap-syndrome/
  • Global initiative for Chronic Obstructive Lung Disease. Global strategy for the Diagnosis, Management, and prevention of chronic obstructive pulmonary disease. GOLD [Internet]. 2016. Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/
  • Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124(2):474–481. doi:10.1378/chest.124.2.474.
  • Viegi G, Matteelli G, Angino A, Scognamiglio A, Baldacci S, Soriano JB, et al. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest. 2004;126(4):1093–1101. doi:10.1378/chest.126.4.1093.
  • Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8):728–735. doi:10.1136/thx.2008.108027.
  • Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Resp Crit Care. 2003;167(3):418–424. doi:10.1164/rccm.200203-183OC.
  • Louie S, Zeki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol. 2013; 6(2):197–219. doi:10.1586/ecp.13.2.
  • Matsumoto K, Seki N, Fukuyama S, Moriwaki A, Kan-o K, Matsunaga Y, et al. Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama Study. Respir Investig. 2015;53(1):22–29. doi:10.1016/j.resinv.2014.08.002.
  • Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:10.1183/13993003.01359-2015.
  • Rodrigo GJ, Neffen H, Plaza V. Asthma–chronic obstructive pulmonary disease overlap syndrome: a controversial concept. Curr Opin Allergy Clin Immunol. 2017;17(1):36–41. doi:10.1097/ACI.0000000000000326.
  • De Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985. doi:10.1371/journal.pone.0062985.
  • Menezes AMB, de Oca MM, Rogelio P, Nadeau G, Fernando C, Lopez-Varela MV, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304. doi:10.1378/chest.13-0622.
  • Chung JW, Kong KA, Lee JH, Lee SJ, Ryu YJ, Chang JH. Characteristics and self-rated health of overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2014;9:795–804.
  • Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2014;11(2):163–170. doi:10.3109/15412555.2013.831061.
  • Marsh S, Travers J, Weatherall M, Williams M, Aldington S, Shirtcliffe P, et al. Proportional classifications of COPD phenotypes. Thorax. 2008;63(9):761–767. doi:10.1136/thx.2007.089193.
  • Miravitlles M, Soriano JB, Ancochea J, Muñoz L, Duran-Tauleria E, Sánchez G, et al. Characterisation of the overlap COPD–asthma phenotype. Focus on physical activity and health status. Resp Med. 2013;107(7):1053–1060. doi:10.1016/j.rmed.2013.03.007.
  • Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12(1):127. doi:10.1186/1465-9921-12-127.
  • Louie S, Zeki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, et al. The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol. 2013;6(2):197–219. doi:10.1586/ecp.13.2.
  • Izquierdo-Alonso JL, Rodriguez-GonzálezMoro JM, de Lucas-Ramos P, Unzueta I, Ribera X, Antón E, et al. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Resp Med. 2013;107(5):724–731. doi:10.1016/j.rmed.2013.01.001.
  • Miravitlles M, Huerta A, Fernández-Villar JA, Alcázar B, Villa G, Forné C, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Out. 2014;12(1):1. doi:10.1186/s12955-014-0120-5.
  • Golpe R, López PS, Jiménez EC, Anón OC, de Llano LAP. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Archivos de Bronconeumología (English Edition). 2014;50(8):318–324. doi:10.1016/j.arbr.2014.06.003.
  • Krokstad S, Langhammer A, Hveem K, Holmen T, Midthjell K, Stene T, et al. Cohort profile: The HUNT study, Norway. Int J Epidemiol. 2012;42(4):968–977. doi:10.1093/ije/dys095.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
  • Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312.
  • Langhammer A, Johannessen A, Holmen TL, Melbye H, Stanojevic S, Lund MB, et al. Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population. Eur Respir J. 2016;48(6):1602–1611.
  • R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2012. ISBN 3-900051-07-0; 2014.
  • Postma DS, Rabe KF. The asthma–COPD overlap syndrome. New Engl J Med. 2015;373(13):1241–1249. doi:10.1056/NEJMra1411863.
  • Wurst KE, Kelly-Reif K, Bushnell GA, Pascoe S, Barnes N. Understanding asthma-chronic obstructive pulmonary disease overlap syndrome. Resp Med. 2016;110:1–11. doi:10.1016/j.rmed.2015.10.004.
  • Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the US population. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2011;8(6):400–7. doi:10.3109/15412555.2011.611200.
  • Kumbhare S, Pleasants R, Ohar JA, Strange C. Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States. Ann Am Thorac Soc. 2016;13(6):803–810. doi:10.1513/AnnalsATS.201508-554OC.
  • Pleasants RA, Ohar JA, Croft JB, Liu Y, Kraft M, Mannino DM, et al. Chronic obstructive pulmonary disease and asthma–patient characteristics and health impairment. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2014;11(3): 256–266.
  • Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald J. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10(9):e0136065. doi:10.1371/journal.pone.0136065.
  • De Marco R, Marcon A, Rossi A, Antó JM, Cerveri I, Gislason T, et al. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J. 2015; 46(3): 671–679.
  • Kim HJ, Baek S, Kim HJ, Lee JS, Oh YM, Lee SD, et al. The impact of smoking on airflow limitation in subjects with history of Asthma and inactive tuberculosis. PLoS One. 2015;10(4):e0125020. doi:10.1371/journal.pone.0125020.
  • Broekema M, Timens W, Vonk JM, Volbeda F, Lodewijk ME, Hylkema MN, et al. Persisting remodeling and less airway wall eosinophil activation in complete remission of asthma. Am J Respir Crit Care Med. 2011;183(3):310–316. doi:10.1164/rccm.201003-0494OC.
  • Langhammer A, Krokstad S, Romundstad P, Heggland J, Holmen J. The HUNT study: participation is associated with survival and depends on socioeconomic status, diseases and symptoms. BMC Med Res Methodol. 2012;12:143. doi:10.1186/1471-2288-12-143.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.